• Study Comparing Radiotherapy Alone to Radiotherapy with Cisplatin for Patients with Sinus or Salivary Gland Tumors

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Belgium France
  • Study on the Long-Term Safety and Efficacy of Nemolizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Bulgaria Czechia Estonia France +8
  • Study of RVU120 and Ruxolitinib for Patients with Intermediate or High-Risk Myelofibrosis

    Not recruiting

    2 1 1 1 1
    Investigated diseases:
    Italy Poland
  • Study on the Effectiveness and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam for Adults with Complicated Urinary Tract Infections or Acute Pyelonephritis

    Not recruiting

    3 1 1 1
    Bulgaria Czechia Estonia Latvia Lithuania Slovakia
  • Study of Exagamglogene Autotemcel (CTX001) for Treatment of Severe Sickle Cell Disease Using Modified Stem Cells

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Belgium Italy
  • Study on the Effects of Dexpramipexole in Adolescents and Adults with Eosinophilic Asthma

    Not recruiting

    3 1
    Investigated diseases:
    Poland Romania
  • Study of Belantamab Mafodotin Alone and with Drug Combination for Patients with Relapsed/Refractory Multiple Myeloma

    Not recruiting

    2 1 1 1
    Investigated diseases:
    France Norway Poland Sweden
  • Study of OPT-302 and Aflibercept for Patients with Wet Age-related Macular Degeneration

    Not recruiting

    3 1 1
    Austria Bulgaria Croatia Czechia Estonia France +10
  • Study Comparing Diclofenac and Thiocolchicoside Injection to Diclofenac Alone for Patients with Acute Moderate to Severe Low Back Pain

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Greece
  • Study of Pembrolizumab with Cisplatin or Carboplatin and Pemetrexed for Patients with Resectable Malignant Pleural Mesothelioma

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Italy

powered by